Novavax has been awarded $1.6 billion in funding for its coronavirus vaccine. The funds will be allocated to late-stage clinical trials and expanding manufacturing. The drugmaker is expected to produce 100 million doses in late 2020 for the U.S. (STAT)

The Trump administration has begun withdrawing from the World Health Organization. A notice has been submitted to the U.N. secretary general that the country will withdraw by July 6, 2021. (CNBC)

Moderna’s trial for its COVID-19 vaccine has been pushed to late July due to disagreements between the pharmaceutical company and government scientists, according to Reuters. The problems have resulted in a two-week delay to the trial start. To date, the federal government has invested nearly half a billion dollars in Moderna’s treatment. (Reuters)

The World Health Organization is investigating new evidence concerning whether coronavirus can spread through air after more than 239 scientists in 32 countries penned a letter about the issue. The organization plans to provide updated guidance on airborne transmission in the weeks ahead. (CNBC)

Shortages of personal protective equipment are occurring once again as coronavirus cases spike. National Nurses United president Deborah Burger cited shortages for masks, gowns, shoe coverings and hair coverings, and addressed concerns around reuse of these items. (AP News)